An innovative business model to aide affordable biosimilars and benefit of mankind
COLLABORATIONS FOR BIOSIMILARS
Starcell Biotech is actively reaching out to global geographies wherein collaboration can be entered for local manufacturing of biosimilar products. We have have mad the impossible now possible with our affordable and innovative technology transfers for production of biosimilars. At current times where in biosimilar costs are high and many a times not affordable, we started Starcell in 2017 to achieve a remarkable feat of making technology transfer both easier and affordable for companies around the globe who wish to collaborate with us for setting up of manufacturing facilities for support of their respective communities.
HIGH QUALITY GENERICS AT AFFORDABLE PRICING
Starcell Biotech is focused on providing High Quality Generic Biosimilars which can be manufactured by using our innovative technologies. We currently cater to array of therapy’s such as bio-betters, yeast & Ecoli platforms for Insulin range of products, mAB’s and Vaccines for varied diseases. We provide our services that enable companies across the globe to benefit from our high quality innovative technologies and thereby benefit mankind by supplying affordable high quality biosimilars to various local companies and governments.